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Toxicology, Structure-Function Relation-
ship, and Human and Environmental
Health Impacts of Polychlorinated
Biphenyls: Progress and Problems
by Stephen Safe
Polychlorinated biphenyls(PCBs) areindustrialcompoundsthathavebeendetectedascontaminantsinalmostevery
componentoftheglobalecosystemincludingtheair, water,sediments,riu, andwildlifeandhumanadiposetissue,milk,
andserum. PCBs incommercial products and environmental extracts arecomplex mixturesofisomersandcongeners
that can now be analyzed on acongener-specific basis usinghigh-resolution gaschromatographic analysis. PCBs are
metabolized prarily viamixed-functionadxdaes intoabroadspectrum ofm-tIbolites. Theresutsindicatethatmetabolk
activation is notrequiredfor PCBtoxicity, andthe parenthydrocarbonsareresponsibleformostofthebiochemical and
toxic responseselicited bythese compounds. Someofthese responses includedevelopmental and reproductive toxicity,
dermaltoxicity, endocrineeffects,hepatotoxicity, carcinogenesis, andtheinductionofdiversephaseIandphaseI drug-
metabolizing enzymes. Many of the effects observed for the commercial PCBs are similar to those reported for
2,3,7,-tetrachlorodibenzo-p-dioxin (TCDD)andrelatedcompounds. Strctur-functionrelaionshipsforPCBcongeners
haveidentifiedtwomajorstncturalclassesofPCBsthatelicit"TCDD-lik"' responses, namely,thecoplanarPCBs(e.g.,
3,3',4A,'-tetraCB, 3,3'4,4,5-pentaCB and3,3',4,4,,5'-hexaCB) andtheirmono-orthocoplanar derivatives. Thesecom-
poundscompetitively bind totheTCDDorarylhydrocarbon (Ah) receptorandexhibit Ah receptoragonistactivity. In
addition, otherstructural dasses ofPCBselicitbiochemical andtoxic responses that are not mediatedthrough the Ah
receptor. Theshor-term effects ofPCBs onoccupationally exposed humans appear to be reversible, and noconsistent
changes in overall mortality and cancer mortality have been reported. Recent studies have demonstrated that some
developmentaldeficitsininfantsandchildrencorrelatedwithin uteroexposuretoPCBs; however, theetiologicagent(s)
orstructuralclasofPCBsresponsiblefortheseeffectshave notbeendlinated. Incontrast, basedonatoxicequivalency
factorapproach, thereproductive anddevelopmental problemsincertainwildlifepopulations appeartoberelatedtothe
TCDD-like PCBcongeners.
Introduction
Polychlorinated biphenyls (PCBs) are industrial compounds
that are readily synthesized via the ferric ion or iron-catalyzed
chlorinationofbiphenyl (1-3). Commercial PCBs were manu-
facturedby severalcompaniesandmarketed worldwide under a
variety of trade names, which included Aroclor (Monsanto,
U.S.A. and United Kingdom), Clophen (Bayer, Germany),
Phenoclor and Pyralene (Prodelec, France), Kanechlor
(Kanegafuchi, Japan), Santotherm (Mitsubishi-Monsanto,
Japan), and Fenclor(Caifaro, Italy). Inaddition, theseproducts
were also manufactured in the U.S.S.R. and Czechoslovakia.
Commercial PCBs aresynthesized, graded, andmarketed accor-
ding to their percentage by weight chlorine content. For exam-
ple, the commercial Aroclors named 1221,1232,1242,1248,1254,
1260,1262, and 1268contain21,32,42,48,54,60,62, and68% by
weightchlorine, respectively, as indicatedbythelast two num-
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bersoftheirfour-digit name. Aroclor 1016isanotherPCB pro-
ductthatresemblesAroclor 1242 incompositionexceptthatthe
penta-andhexachlorobiphenyl components havebeenremoved.
Thechemicalproperties ofthecommercial PCBmixtures are
dependentontheirdegreeofchlorination; forexample, thelower
chlorinated mixtures are mobile, colorless oils, whereas the
higher chlorinated Aroclors 1262 and 1268 are an immobile,
viscous liquid and an amorphous solid, respectively. The esti-
mated worldwide production of PCBs is approximately 1.5
millionmetrictons(2). Thewidespreadindustrialutilizationof
PCBproducts wasduetotheirvariablephysicalproperties (i.e.,
liquid to solid), chemicalstability, dielectric properties, inflam-
mability, andmiscibilitywithorganicsolvents. PCBshavebeen
used asheattransferfluids, hydraulic lubricants, dielectric fluids
for transformers and capacitors, plasticizers, wax extenders,
adhesives, organic diluents, dedusting agents, pesticide ex-
tenders, cutting oils, carbonless reproducing paper and flame
retardants.The widespreaduseofPCBscoupledwithimproper
disposalpracticeshasresultedintheirintroductionintotheen-
vironment. Moreover, due to the relative stability ofthe more
highlychlorinated PCBsandtheirlipophilicity, PCBsarewidelyS. SAFE
distributed and transported throughout the environment, and
their residues have been identified in air, water, aquatic and
marine sediments, fish, andwildlifeandhumanadiposetissue,
serum, and milk (2). PCBs, along with DDT and some ofits
metabolites, are among themostwidely identifiedorganic con-
taminants found in extracts from almost all environmental
samples.
PCB Analysis and Environmental
Impact
The chlorination ofbiphenyl is not highly regiospecific and
results intheformationofacomplexmixtureofisomersandcon-
geners (1,3). ThecompositionofthedifferentAroclormixtures
is dependent on their degree of chlorination because there is
generally anincrease inthemorehighly chlorinated congeners
with increasing chlorination. Early analytical studies on com-
mercial PCBs using gas liquid chromatography (GLC) clearly
demonstratedboththecomplexityofthesemixturesandthedif-
ferences inchromatographic patterns, whichweredependenton
theirdegreeofchlorination (1). Theanalysisofenvironmental
extractsby low-resolutionpackedcolumnGLCutilizesspecific
peakspresentinthechromatogramsofthecommercialPCBs(or
reconstitutedmixturesofdifferentproducts) toestimatethePCB
levels (4). This method relies heavily on the limited pattern
recognitionofselectedpeaks; however, inmanycasestheGLC
pattern ofPCBs in many environmental extracts do not resem-
blethecorrespondingpatterns observed foranyofthecommer-
cial PCBs (5-9).
The problems associated with PCB analysis have been re-
solved with the development ofhigh-resolution capillary col-
umns andthesynthesis ofall209PCBisomersandcongeners as
reference standards (10). Safe and co-workers (6,11) first
described the high-resolution GLC analysis of a commercial
PCB, Aroclor 1260, andanextractfromacompositehumanmilk
sample. At least 88 different congeners were identified in
Aroclor 1260, whereasonly55 individual PCBswereidentified
in thehumanmilk sample. Surprisingly, 11% ofthetotal PCBs
identified inthelattersamplewerethelowerchlorinated2,4,4'-
trichlorobiphenyl (triCB, 8.8%)and2,4,4 5-tetrachlorobiphenyl
(tetraCB,2.2%), congeners thatareminortotracecomponents
of Aroclor 1260. The reason for the persistence of the lower
chlorinated PCBs, particularly2,4,4'-triCB, inhumantissuesis
unknown. Several PCBcongenersidentified inthemilksample,
including 2,2 ',4,4 '5,5 '-hexachlorobiphenyl, (hexaCB),
2,2'3,4,4',5'-hexaCB, 2,2',3,3 4,4'5-hep tachlorobiphenyl
(heptaCB), and2,2'3,4,4',5,5'-heptaCB, aremajorcomponents
ofAroclor 1260.2,3,3',4,4 5-HexaCBisalsoamajorPCBcom-
ponent ofthehuman milk extract but is a minor componentof
Aroclor 1260. ItwasalsoofinteresttonotethatseveralPCBcon-
geners that are major components (22.8% oftotal) ofAroclor
1260 [2,2'3,5',6-pentaCB(2.7%); 2,2'3,4'5',6-hexaCB(7.4%);
2,2'3,4,5,5',6-heptaCB (4.1%); 2,2 3,3 4,5,6'-heptaCB (5.5%);
2,2'3,3'4,4'5,6-octachlorobiphenyl (3.1%)] are present in on-
ly trace levels (0.81% oftotal) inthehumanmilkextracts. With
the exception of 2,2'3,3'4,4' 5,6-octachlorobiphenyl, all, of
these compounds possess a 2,3,6-trichloro- or 2,5-dichloro-
substitution pattern on at least one of their phenyl rings and,
because ofthe two adjacent unsubstituted carbon atoms, rapid
metabolicdegradationofthecongenerswouldbeexpected (11).
The failureoftheoctachlorobiphenyl toaccumulate in humans
maybeduetouptakefactors, asthepersistenthigherchlorinated
PCBs (C18-C110) are notmajorcontaminants in human tissues.
Schulz et al. (12) have recently reported the complete char-
acterizationofthePCBcongeners inAroclors 1016, 1242, 1254,
and 1260, Clophens A30, A40, A50, and A60 by multidimen-
sionalGLC-electroncapturedetection. Atotalof132ofthe209
possiblecongeners wereidentifiedinthesemixtures, andthese
datawillbeusefulforcarryingouttheunambiguousquantitative
analysis of PCBs in extracts from different environmental
matrices. Several studies have already reported the high-
resolutionGLC analysisofPCBsintheenvironment, and some
oftheresultsweresummarizedby McFarlandandClarke(13).
TheuptakeandretentionofindividualPCBcongenersisdepen-
dentontheanimal speciesandthecongenercompositionofthe
various local sources ofPCB contamination. Inspection ofthe
analyticaldata(13)indicatesthattherearemajordifferences in
thePCBcompositioninfish, wildlife, andhumans;however, the
congeners that appear most frequently in all analytes are
2,2'3,4,4',5'-hexaCB,2,2',4,4',5,5'-hexaCB and2,2'3,4,4',5,5-
heptaCB. Thepotentialadverseenvironmenta andhumanhealth
impacts ofPCBs is dependent on several factors including the
overall levels ofPCB exposure, the toxicities ofthe individual
congeners present in themixture, andtheir interactive effects.
Someofthesefactorsandtheirimportancewillbeaddressed in
this review.
Role of Metabolism in the Toxicity of
PCBs
Thetoxiceffectselicitedbymanydifferent structural classes
of chemicals require their metabolism into activated inter-
mediates, which subsequently alkylatecritical cellular macro-
moleculartargets (14,15). Themetabolic activationprocess for
many different halogenated hydrocarbons often involves
cytochromeP450-dependentoxidationortransformationofthe
hydrocarbontoformareneoxideorradicalintermediatesthatare
capableofformingcovalentadducts withcellularconstituents.
Early studies with PCBs clearly demonstrated that these
hydrocarbonsareconvertedintopolarhydroxylatedmetabolites
andtheresultsofstudieswithindividualPCBcongenersarecon-
sistent with the metabolic scheme illustrated in Figure 1
(11,16-19). PCBsaresubstratesforP-450enzyme-catalyzedox-
idation intohighly reactiveareneoxideintermediates, which in
turn rearrange to give phenolic metabolites or are further
metabolizedviavariousmetabolicpathways. Forexample, epox-
idehydrolaseandglutathioneS-transferasescatalyzetheconver-
sionofareneoxidesintodihydrodiolsandglutathioneconjugates,
respectively. Inaddition, thephenolicmetabolitescanundergo
further oxidative metabolism and/or conjugation, and gluta-
thione conjugates are precursors of a number of sulfur-
containing metabolitesincludingthemethylsulfonylcompounds.
TherateofPCBmetabolismandtheregioselectivityofthein-
itial arene oxide formation are dependent on several factors,
whichincludea)thedegreeofringchlorination, b)thechlorine
ring substitutionpattern, andc) thepattern and levelsofP-450
isozymes and other drug-metabolizing enzymes in the target
organ. For example, phenobarbital-induced P-4502 isozymes
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FIGURE 1. Proposed metabolic scheme for the PCBs.
catalyze the metabolism of dichlorobiphenyls with diortho
chlorine substitution, whereas P-4501 isozymes primarily
metabolize dichlorobiphenyls, whichdo notcontain any ortho
chloro substituents. In contrast, mono-ortho-chloro-substituted
dichlorobiphenyls are metabolized byboth inducedP-4501 and
P-4502 isozymes (20). There is also evidence that PCBs may
alsobeoxidized viapathways thatdo notinvolve areneoxide in-
termediates (21).
The biochemical and toxic responses associated with PCB
metabolism havebeen investigated. Theresultsofin vivoandin
vitro studies show thatPCBs formcovalentadductswithcellular
macromolecules (protein, RNA, and DNA) and induce DNA
strandbreaksand DNArepair(22-27). Presumablytheseevents
are dependent on the metabolism ofPCBs into intermediates
such as areneoxides, whichalkylatecellular macromolecules.
In contrast, PCBs are notbacterial mutagens (28) and in many
cases those PCBs that are most readily metabolized are among
the leasttoxic membersofthisclassofcompounds. Onbalance,
it would appear that PCBs are not genotoxic and the metabolic
activation process per sedoes not play a significant role in the
toxicity ofPCBs.
Several studieshavedemonstrated thatthemethylsulfonyl PCB
metabolites (29-33)exhibit some unusual biochemical proper-
ties. For example, methylfsulfonyl PCB metabolites bind to
uteroglobin, aprogesterone-binding protein (34). Inaddition,
methylsulfonyl metabolites such as 4,4'-bis(methylsulfonyl)-
2,2'5,5'-tetrachlorobiphenylaccumulate inlungtissue, where
itappearstobindwithmoderatelyhighaffinitytoalung-binding
protein (35). Methylsulfonyl metaboliteshavebeenidentified in
human subjects and in relatively high levels in individuals ac-
cidentlyexposedtoPCBsintheYushopoisoning incident(36).
Because changes in lung capacity and function in humans has
beenassociatedwith PCBexposure (37), ithasbeensuggested
thatthemethylsulfonyl PCB metabolites may playa role in the
etiology ofthis toxic response.
HydroxylatedPCBmetaboliteshavebeenidentifiedinwildlife
samples(38), andseveralinvitrostudieshaveshownthatthese
compounds are potent inhibitors of mitochondrial oxidative
phosphorylation (39). However, a number of hydroxylated
metabolitesofsomeofthemoretoxicPCBcongeners(e.g., 3,3'
4,4 5-pentaCB)havebeenidentified, subsequentlyadministered
to laboratory animals, and shown to be relatively nontoxic.
(40-42).
Thus, althoughPCBsaremetabolized, inpart, througharene
oxideintermediatestogiveanumberofmetabolicproducts, the
evidence suggests that PCB metabolism serves primarily as a
detoxification process. These results imply that the toxic and
biochemical responses associated with exposure to PCB mix-
tures and congeners areprimarily due to the parent hydrocar-
bons. Thisisincontrasttomanyotherclassesofxenobioticsin-
cludingchlorinatedhydrocarbonsandthehalogenatedbenzenes,
inwhichmetabolicactivationplaysacriticalroleintheirtoxicity
(14,15).
PCB Mixtures: Biochemical and Toxic
Responses
Thetoxic andcarcinogenic responseselicitedbycommercial
PCBmixtureshavebeenextensively investigated inlaboratory
animals, mammalian cells in culture, and in exposed human
populations(3,43-47). ThePCB-inducedeffects aredependent
onanumberoffactorsincludingtheage, sex, andspeciesofthe
test animals, the route of administration, the duration of ex-
posure, andthechlorinecontentofthePCBmixture. Forexam-
ple, inSprague-Dawley ratsfedadietofAroclor 1260for2years
(100ppmfor 16monthsand50ppmfor8months), theincidence
ofhepatocellular adenocarcinomas was51% in female ratsand
0% inmalerats(48). Schaefferandco-workers (49)usedmale
Wistar rats as model for determining the effects of chronic
feedingof100ppmofClophenA42andClophenAM0. After800
days, theincidenceofhepatocellularcarcinomasintheClophen
A60, ClophenA30andcontrol rats was 61, 3, and2%, respec-
tively. This studyillustratedthesignificantdifferencesbetween
thehepatocarcinogenicityofthemorepotent,higherchlorinated
Clophen A60 PCB (60% Cl by weight) versus the lower
chlorinated Clophen A30 (42% Cl by weight). Moreover,
becausethechemicalcompositionofAroclor 1260andClophen
AOaresimilar, theresultsofthechronicfeeding studiesby Nor-
backandWeltman (48)andSchaefferandco-workers(49)also
indicateintraspeciesdifferences inmaleratsusceptibility tothe
hepatocarcinogenicity ofPCBs.
Theacute, subacute, andsubchronictoxicresponsestocom-
mercialPCBsarecharacterizedbyLD5ovaluesthatareusually
> 1000mg/kg, anextensivearray ofhepatotoxiceffects, body
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weightlossinsomestudies, someimmunotoxicity andeffectson
the gastrointestinal system, dermal lesions (primarily in pri-
mates), anddevelopmental andreproductivetoxicity. Inchronic
feeding studies, mostoftheabovetoxicresponseswereobserv-
ed; in addition, several studies have reported that PCBs ad-
ministered alone are carcinogenic, with the liver being the
primary targetsite(47-49). Ithasalsobeenreportedthatmink
andmonkeys wereamongthemostsensitive species tothetox-
ic effects ofcommercial PCBs (50-53).
Thebiochemical properties ofPCBmixtures have also been
extensively investigated, and one ofthe hallmarks ofPCB ex-
posureistheinductionofphaseIandphaseIIdrug-metabolizing
enzymes (43,46). Forexample, several commercial PCB mix-
tures induce the phase II enzyme systems, epoxide hydrolase,
glucuronosyl transferase, glutathione S-transferases and reduc-
tase(54-56). Inaddition, PCBmixturesinduceabroadspectrum
ofP450-dependent monooxygenase enzymeactivities including
severalpolynuclear aromatichydrocarbonhydroxylases, steroid
hydroxylases, O-dealkylases, severalhaloaromatichydroxylases,
N-dealkylases, barbituate hydroxylases, and the oxidative
metabolismofahostofothersubstratesincluding aflatoxin, war-
farin, aldrin,acetanilide, etc. (43,46,5758). Earlystudiesonthe
effects of drug-metabolizing enzyme inducers showed that
phenobarbital (PB) and 3-methylcholanthrene (MC) werepro-
totypes oftwo different classes ofmixed-function oxidase in-
ducers(59-61). Incontrast, theinductionactivitiesofcommer-
cialPCBs suchasAroclor 1254resembledthoseofPBplusMC
(coadministered), and Aroclor 1254 and other PCB mixtures
were designated as mixed-type inducers (62-64). Subsequent
research has shown that the differences in PB and MC as in-
ducers wereduetotheirpreferential inductionofdifferentP-450
isozymes (65-68) Phenobarbital induces CYP2B1 (P-450b) and
CYP2B2 (P-450e), MC inducesCYPlAI (P-450c)andCYPLA2
(P-450d), and both chemicals induce low levels of CYP2A1
(P-450a). Notsurprisingly, Aroclor 1254inducedall fiveP450
isozymes. Itwas therefore ofinterest to determine which PCB
congeners were responsible for not only for the induction ac-
tivitiesofthecommercial PCBmixturesbutalsoforthetoxicef-
fects elicited by the compounds.
PCB Congeners: Structure-Function
Relationships
The structure-activity relationships (SARs) for several dif-
ferentstructural classes ofPCBshavebeencarriedout, andthe
results ofthese studies have delineated many ofthe PCB con-
geners that are responsible for the toxic and biochemical ac-
tivities associatedwiththecommercial andenvironmental mix-
tures (69-73).
PCBs That Exhibit TCDD-like Activity
Coplanar Congeners. Structure-induction and structure-
toxicityrelationshipsforPCBshavedemonstratedthatthreePCB
congeners (Fig. 2), namely, 3,3',4,4'-tetrachlorobiphenyl
(tetraCB), 3,3',4,4',5-pentachlorobiphenyl (pentaCB) and
3,3,4,4',5,5'-hexachlorobiphenyl (hexaCB) elicitthe same spec-
trumoftoxicandbiochemical responsesobservedforTCDDand
relatedhalogenatedaromatichydrocarbons(43,46,57,58,74-76).
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FIGURE2. Thestructuresof2,3,7,8-ICDD, thecoplanarPCBs, andthederived
mono-ortho coplanar analogs.
As illustratedinFigure2, intheircoplanarconformationthese
three congeners and 3,4,4'5-tetraCB are approximate iso-
stereomersofTCDDinwhichtheClgroupsaresubstitutedon-
ly in the lateral-(para and meta) positions. Structure-activity
studies have shown thattwo para (4 and 4'), two or more meta
(3,3' and 5) and no ortho (2,2',6 and 6') substituents are re-
quiredformaximumTCDD-likeactivities. ThecoplanarPCBs
competitivelydisplace[3H]TCDDfromthecytosolicAhrecep-
tor (77), andthese compounds exhibit all theproperties ofAh
receptor agonists including the induction of CYPlAl and
CYP1A2 (54).
Mono-orthoCoplanarCongeners. Austandco-workers(78)
first demonstrated that the mono-ortho-substituted poly-
brominated biphenyl (PBB), 2,3 4,4'5,5'-hexabromobi-
phenyl, resembled the commercial PBB mixture, FireMaster
BP-6, and Aroclor 1254 as a mixed-type inducer of rodent
hepaticdrug-metabolizing enzymes. Subsequent studies showed
thatallthemono-orthocoplanarPCBs(Fig. 2) weremixed-type
inducers and resembled Aroclor 1254 in their pattern ofdrug-
metabolizingenzyme induction (46,54,79-81). Themono-ortho
coplanar PCB congeners also competitively displaced [3H]
TCDD from the cytosolic Ah receptor (77), and the results of
limited studies have demonstrated that this structural class of
PCBsexhibitsAhreceptoragonistactivity (54,82-88). However,
quantitative SARshaveshownthattherelativeAhreceptorbind-
ing affinities and Ah receptor agonist activities followed the
order TCDD > 3,3'4,4'5-pentaCB > 3,3'4,4'-tetraCB and
3,3',4,4',5,5'-hexaCB > mono-orthocoplanar PCBs.
OtherPCBsAsAhReceptorAgonists. Atleasttvoadditional
structural classes ofPCBs havebeenidentified as Ah receptor
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agonists. The 17di-orthocoplanarderivativesofthe4coplanar
PCBs and 3,4,4'-trichlorobiphenyl have been synthesized and
tested as inducers of rodent microsomal aryl hydrocarbon
hydroxylase (AHH)activityandtheassociatedP-450isozymes
(54,89,90). The results indicated that at relatively high doses,
mostofthedi-orthocoplanarPCBsthathavebeentestedinduce
AHH activity and appear to be weak Ah receptor agonists.
Limitedstudieshavealsodemonstratedthatsomeofthesecon-
geners elicit other TCDD-like responses; for example,
2,2 ',3,3 '4,4'-hexaCB and 2,2 ',3,4,4 ',5 '-hexaCB are por-
phyrinogenic in rodents, and 2,3 ',4,4',5 ,6-hexaCB induced
AHH activity and suppressed the splenic plaque-forming cell
responseto sheep redbloodcells in C57BL/6mice (85,91). At
least one compound inthis structuralclass, 2,2',4,4',5,5'-hexa-
CB, was notanAhreceptoragonistandresembledPBinitspat-
ternofdrug-metabolizingenzymeinduction(54). DavisandSafe
(85) also reported that atleast two congeners, 2,3,3',4,5'-pen-
taCB and 2,3,3 ',4,5,5 '-hexa CB, are also immunotoxic in
C57BL/6 mice, andthe formercompoundalsoinducedhepatic
microsomal AHH activity. Thesecongeners structurally resem-
blemono-orthocoplanarPCBs inwhichoneofthepara substi-
tuentshasbeenremoved. Thesecompoundsandsomeofthedi-
orthocoplanarPCB analogsexhibitlowcompetitivebindingaf-
finitiesfortheAh receptorandexhibitedpotenciesasAhrecep-
tor agonists that wereconsiderably lowerthanthemono-ortho
coplanar PCBs.
BiochemicalandToxicResponsesofPCBs ThatDoNotAct
through the Ah Receptor. There is interest by scientists and
regulatory agencies in regulating PCBs on a congener basis
(92,93). Theidentification andrelativepotenciesforsomeofthe
TCDD-like congeners have been determined in several in vivo
and in vitro bioassays [reviewed in Safe (46)]. However, any
scheme that is devised forcongener-based regulation ofPCBs
must also take into account the potentialtoxicitiesand adverse
human and environmental health effects of other structural
classesofPCBcongeners. Itwasapparentfromtheinitialstudies
withAroclor 1254thatPCBsalsoresembledPBintheirpattern
ofdrug-metabolizing enzymeinduction. Moreover, several in-
dividual congeners, including2,2',44'-tetraCBand,2,2',4,4',5,
5'-hexaCB, have been characterized as pure PB-type inducers
andstrucure-activity studies suggestthatcompoundssubstituted
in atleasttwopara andtwoortho substituents exhibitthistype
ofactivity (95). Athoroughstudyofthepotentialadversehealth
effects ofthisclassofPCBshas notbeendetermined. However,
likePB, thesecompoundscausehepatomegalyandexhibitactivi-
ty aspromoters in short-termbioassaysforcarcinogenesis. For
example, 2,2',4,4',5,5 '-hexaCB promotes diethylnitrosamine-
induced ATPase-deficient lesions in rat liver(95,96).
Ithasalsobeenreportedthatotherstructural classesofPCBs
are inducers of P-450 isozymes. For example, several highly
chlorinated congeners with two or more ortho substituents in-
duced CYP3A1 (P-450) in cultured rathepatocytes (97). This
P-450 isozyme is classically induced by dexamethasone and
relatedglucocorticoids (96). Thetoxicological significance of
this PCB-induced biochemical response is unknown. Several
studies havereported theneurobehavioral toxicityofcommer-
cial PCBs and individual congeners in rodents (98-106).
Although someoftheobservedresponseshavebeenassociated
with 3,3',4,4'-tetraCB, a TCDD-like congener (102-104), the
neurotoxicity of other structural classes of PCBs have been
reported (105,106). For example, studies on the structure-
dependentdecreaseinthedopaminecontentofPC12cellsshow-
edthatthemostactivecongenerwas2,2'-dechlorobiphenyl and
othercongenerswithrelativelyhighortho(twotothree)andpara
(up to two) but low meta substitution were also active (106).
Many ofthecompounds that were active in the in vitro studies
alsocausedasimilardecreaseinthedopaminecontentinbrain
tissueofrodentsandnonhumanprimates(105). Thesedatasug-
gestthat someoftheseortho-substituted PCBs may alsoplay a
roleinthetoxicities elicitedby PCB mixtures. Theadverseen-
vironmental and human health impacts of these more highly
ortho-substitutedPCBcongeners areunknownandrequirefur-
ther investigation.
Human Health Effectsof PCBs
The human health effects of PCBs have been reviewed
(45,107-110). Exposure ofhumans to relatively high levels of
PCBs has occurred primarily in individuals working in plants
thatextensivelyusedPCBsandPCB-containingequipment. Oc-
cupational exposure to PCBs can result in abroad spectrumof
symptomswhichincludeelevated serumlipidlevels, increased
levelsofsomeserumenzymes, chloracneandrelateddermal le-
sions, possible hepatic damage, and respiratory problems
(37,111-116). It is noteworthy that theeffects ofPCBs were not
consistentlyobservedinalltheoccupationallyexposedworkers,
and it is possible that some ofthe responses may be due to the
highlytoxicpolychlorinated dibenzofurans (PCDFs), whichare
presentasby-productsincommercialPCBs(117,118). Theacute
and subacute effects of PCBs associated with the Yusho and
YuchengaccidentsinJapanandTaiwan, respectively, willnotbe
discussed inthis review because theevidence suggests thatthe
toxic responsesobservedinthevictimsoftheseexposures were
duetotherelativelyhighlevelsofPCDFsthatwereidentifiedas
by-products inthe PCB-containing industrial fluid (119,120).
Epidemiologicalstudiesonseveralgroupsofworkersoccupa-
tionally exposed to PCBs have been reported (121-124). The
results from these studies were variable and did not show any
consistenttrendswithrespecttooverallmortalityordeathsfrom
specific cancers. For example, in a study by Bertazzi and co-
workers (123) on a group ofcapacitor workers, cancer deaths
wereelevatedinthemaleandfemaleworkers andoverall mor-
tality was also increased in the latter group. Their results sug-
gested that increased cancer in lymphatic and hemopoietic
tissues andthegastrointestinal tract wereassociated with PCB
exposure. Incontrast, asecondstudy(122)showedthattherewas
adecreasedoverallmortalityandmortality fromcancerin2588
capacitor workers. There were some increases in specific
cancersinthisgroup(e.g., liver, gallbladder, andbiliarytract);
however, duetoconfoundingfactorsitwasdifficulttoassociate
thesespecific cancerswithPCBexposure. Thus, atthepresent
time, the results suggest that the adulthuman population most
highly exposedto PCBsdoes notshow any consistent increase
inmortality orspecific cancers. However, because mostofthe
epidemiology reports were limited due to the sizeofthe study
grouporthenumberofdeaths, thelong-term effectofoccupa-
tional exposure to PCBs will require furthermonitoring ofthe
worker population. Interestingly, Taylor and co-workers
(125,126) have reported that small but significantdecreases in
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birth weight wereobserved ininfantsborn to womenemployed
incapacitor-manufacturing plants. This suggeststhatinfants may
be at risk from in utero exposure to PCBs.
The effects ofPCBs on infant growth and development have
been investigated in twopopulations, namely, a groupofchildren
in Michigan whose mothers consumed moderate quantities of
fishand a groupofNorthCarolinachildren (127,128). Thelevels
ofPCBs inboth study groups were relatively low and resembl-
ed those observed in most normal populations. In one study
(128), birth weight, headcircumference, and neonataljaundice
showed no relationship tothelevelsofPCBs orDDE inhuman
milk. In contrast, lower birth weights and a small head cir-
cumferencecorrelated withPCB exposure asmeasuredby fish
consumption orcord serumPCBlevels (127). The reasonforthe
differences in the results ofthese studies have not been deter-
mined. Despite these differences, there were a number of
similarities betweentheresultsobtained fromtheMichiganand
North Carolina groups. Prenatal exposure to PCBs was cor-
related with poorer performance on the Brazleton Neonatal
BehaviorAssessment Scaleand onthepsychomotorindexofthe
Bayley Scales ofInfantDevelopmentby infants fromboth study
groups (127-130). Moreover, intheMichiganfish-eating group,
exposure toPCBs (highcord serumlevels ormaternalfish con-
sumption) also correlated with poorerperformance on Fagan's
Visual Recognition MemoryTest(131). In asubsequentfollow-
up study in thechildren at4 yearsofage, the poorer short-term
verbal andquantitative memory function inboth was related to
the PCB concentrations in cord serum (132). Moreover, their
growth rateandreducedactivitybased oncompositeratingsalso
correlated with PCB levels (133).
Comparable effects oninfantandchilddevelopmenthavealso
been observed in the offspring of women exposed to PCBs,
PCDFs, andrelatedcompounds intheYuchengpoisoning inci-
dent (134). There are several unresolvedproblems with respect
totheobserveddevelopmental deficits andtheetiology ofthese
effects. For example, are the same developmental problems
associated with the Michigan, North Carolina, and Yucheng
groups; what isthedurationoftheseeffects; aretheseproblems
in the Michigan and North Carolina children associated with
PCBs or an as yetunidentified groupoflipophiliccontaminants;
are the PCBs, PCDFs, or both groups ofcompounds etiologic
agents intheoffspring oftheYuchengmothers; ifthePCBs are
etiologic agents, arethedevelopmentalproblems associated with
dioxinlike Ah receptor agonists or other structural classes of
PCBs? Thesequestions mustbeaddressed inordertoresolvethe
possible (but notproven) roleofPCBs onthe health ofapoten-
tially sensitive group: infants and children.
RiskAssessment of PCBs on a
Congener-Specific Basis: Develop-
ment of Toxic Equivalency Factors
The development oftoxic equivalency factors (TEFs) forthe
risk assessment ofpentachlorodibenzo-p-dioxin (PCDD) and
PCDF mixtures has beenadopted worldwideby several regula-
toryagencies(46,135-139). Thisapproachtakesadvantageofthe
common Ah receptor-mediated mechanism of action for the
PCDDs and PCDFs and uses the expected structure-activity
relationships for these congeners to determine their potencies
Ihble1.RelativetoxicpotenciesandproposedTEFsforPCBcongeners(46).
Potency rangea
Congener (in vivo and in vitrv) TEFb
3.3 '4,4',5-PentaCB 0.3-0.0006 0.1
3,3'4,4'55 '-Hexa CB 0.1-0.0012 0.05
3,3'4,4'-TetraCB 0.009-0.00008 0.01
Mono-ortho coplanar PCBs 0.00045-0.0000014 0.001
Di-ortho coplanar PCBs 0.00002 0.00002
Abbreviations: TEF, toxicequivalency factor; PCB, polychlorinated biphenyl.
aThe potencies of the individual congeners were determined relative to
2,3,7,8-TCDD for several different Ah receptor-mediated responses.
bProposed by Safe (46)
relativetoastandardtoxin, 2,3,7,8-TCDD. ThePCDD/PCDFex-
tracts from most environmental samples primarily contain the
2,3,7,8-substitutedtetra-octachlorinated compounds, and indivi-
dual TEF values have been derived for all ofthese congeners.
The validation of the TEF approach for risk assessment of
PCDDs andPCDFshasbeenreviewed(46), andthereis strong
evidencethatthisapproach is useful forpredicting TCDD-like
responses.
Tanabeandco-workers (140-144) firstusedaTEFapproach
forassessingtheTCDDortoxicequivalence (TEQ)ofPCBs in
the commercial mixtures and in environmental extracts (note:
TEQ = E [PCDD x TEF] + E[PCDF x TEF]). The TEF
valuesadoptedforthecoplanarandmono-orthocoplanarPCBs
werederivedfromtherelative potenciesofthesecompounds as
inducers ofAHHorethoxyresorufin O-deethylase (EROD) ac-
tivities inrathepatomaH-4il Ecellscompared to2,3,7,8-TCDD
as thetoxic reference standard (145).
Recently, Safe (46) summarized the TEF values for the
coplanarandmono-orthocoplanarPCBs (Table 1)and, basedon
the range of values, the following TEFs were proposed:
3,3 '4,4'5-pentaCB, 0.1; 3,3 '4,4 '5,5 '-hexaCB, 0.05;
3,3',4,4'-tetraCB, 0.01; mono-orthocoplanarPCBs, 0.001. These
valuesarehighly conservative and will requiremodificationas
newdatabecomeavailable. Inaddition, itshouldbestressedthat
the TEF approach applies only to those congeners that act
through the Ah receptor and is applicable only to TCDD-like
responses.
OneoftheearliestapplicationsoftheTEFapproach wasused
todeterminethecontributionofPCBcongenerstothetotalTEQs
in samples containing PCBs, PCDDs, and PCDFs (140-144,
146-153). Initialresultsindicatethatinmostenvironmental ex-
tracts, PCBscontributesasignificantly higherpercentageofthe
total TEQs than the PCDD plus PCDFs (combined). A recent
paper by Dewailly and co-workers (146) identified six major
coplanar and mono-ortho coplanar PCBs in human milk
(3,3',4,4'-tetraCB, 3,3',4,4'5-pentaCB, 3,3'4,4',5,5'-hexaCB,
2,3,3 4,4'-pentaCB,2,3 4,4'5-pentaCB, and 2,3,3' 4,4'5-
hexaCB), andtheTEQ value forthesecongeners derived from
the TEF values in Table 1 was 37.76 ppt. In contrast, the TEQ
valueforallthe2,3,7,8-substitutedPCDDsandPCDFswas 13.22
ppt. Thus, the PCBs constituted 74% ofthe total TEQs in the
human milk samples from the province of Quebec. Recent
studiesonextractsfromGreatLakesfishandbirds(147-153)have
reportedthat 3,3',4,4'5-pentaCB and2,3,3'4,4'pentaCB were
the major toxic PCB congeners present, and the PCBs con-
tributed significantly more to the TEQs than the PCDDs plus
PCDFs. Moreover, there was a correlation between the repro-
ductive failure in the wildlife populations and thePCB-TEQs.
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Theseresultsclearly demonstrate theutility oftheTEFapproach
forriskassessmentofPCBsinsomeenvironmental samples and
show their possible etiologic role in some adverse effects on
wildlife population. Future studies should focus on further
evaluation andvalidationoftheTEFapproachfortheriskassess-
mentofPCBswhichexhibitIXCDD-likeactivities. Inaddition,
the possible role ofother structural classes ofPCBs on PCB-
induced toxicosis must be evaluated.
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